awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37672654-50D8AC35-E9FF-485B-8115-7535C8778A41
Q37672654-50D8AC35-E9FF-485B-8115-7535C8778A41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37672654-50D8AC35-E9FF-485B-8115-7535C8778A41
Controlling escape from angiogenesis inhibitors.
P2860
Q37672654-50D8AC35-E9FF-485B-8115-7535C8778A41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37672654-50D8AC35-E9FF-485B-8115-7535C8778A41
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5401b9ee949582aa48ded53ccb75644cc8c29309
P2860
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.